Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on April 28, 2021. The filing addresses corporate governance matters regarding the scheduling of the 2021 Annual Meeting of Stockholders. Note: The input metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.08 (Shareholder Director Nominations) and contains no financial statements or performance data.
Material Changes
The primary material change reported is the rescheduling of the 2021 Annual Meeting of Stockholders:
- New Meeting Date: June 24, 2021.
- Record Date: April 29, 2021.
- Reason for Filing: The meeting date was changed by more than 30 days from the anniversary of the 2020 Annual Meeting, triggering a requirement to disclose the deadline for stockholder proposals and director nominations.
Guidance, Outlook, and Risks
The filing contains no management commentary on business outlook, financial guidance, risks, contingencies, or unusual items. The document strictly outlines procedural deadlines for shareholder engagement:
- Proposal Deadline: Stockholder proposals or nominations for inclusion in the proxy statement must be received by 5:00 p.m. Eastern Time on May 7, 2021.
- Compliance: Proposals must comply with Rule 14a-8 under the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is NanoVibronix, Inc., not Envue Medical, Inc.
- Confirm the record date of April 29, 2021, to determine eligibility to vote at the June 24, 2021, Annual Meeting.
- Note the May 7, 2021, deadline for submitting qualified stockholder proposals or director nominations.
- Review the company's proxy statement (when filed) for details on the agenda and nominees.